Urine Markers of Kidney Tubule Cell Injury and Kidney Function Decline in SPRINT Trial Participants with CKD.

Rakesh MalhotraRonit KatzVasantha JotwaniWalter T AmbrosiusKalani L RaphaelWilliam HaleyAnjay RastogiAlfred K CheungBarry I FreedmanHenry PunziMichael V RoccoJoachim H IxMichael G Shlipak

Published in: Clinical journal of the American Society of Nephrology : CJASN (2020)

Urine markers of tubule cell injury provide information about risk of subsequent loss of kidney function, beyond the eGFR and urine albumin.

Keyphrases

single cell
cell therapy
small cell lung cancer
chronic kidney disease

clinical trial
healthcare
epidermal growth factor receptor

randomized controlled trial
stem cells
mesenchymal stem cells

open label
body composition
resistance training